Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study

• Main Authors: Alexandra Okihiro (Author), Rachana Hasija (Author), Lillia Fung (Author), Bonnie Cameron (Author), Brian M. Feldman (Author), Ronald Laxer (Author), Rayfel Schneider (Author), Earl Silverman (Author), Lynn Spiegel (Author), Rae S. M. Yeung (Author), Shirley M. L. Tse (Author)
• Format: Book
• Published: BMC, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Anti-TNF (Tumor necrosis factor) therapy is effective in treating pediatric patients with refractory rheumatic disease. There is however a concern that anti-TNF usage may increase the risk of malignancy. Reports on specific types of malignancy in this patient population have been...